Reshma Kewalramani, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,714 shares at $272.77 ($1.0M) on 2020-05-06, disclosed to the SEC on 2020-05-08.
Open-market sale of $1.0M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $270.35 | 416 | $112K | 11.1% |
| 2 | $270.35 | 416 | $112K | 11.1% |
| 3 | $271.92 | 300 | $82K | 8.1% |
| 4 | $272.77 | 360 | $98K | 9.7% |
| 5 | $272.77 | 360 | $98K | 9.7% |
| 6 | $274.04 | 864 |
| $237K |
| 23.4% |
| 7 | $274.04 | 864 | $237K | 23.4% |
| 8 | $275.17 | 134 | $37K | 3.6% |
| Total | $272.84 avg | 3,714 | $1.0M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |